Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Sberbank reported for 2024 by RAS

1/17/25 SBER

Samolet is conducting a bond buyback

1/16/25 SMLT

Etalon started selling apartments in Residential Complex Cranberry.Park

1/16/25 ETLN

Lukoil bought a large office near Belorussky railway station

1/16/25 LKOH

Rusal reduced the vanadium content in aluminum by ten times

1/16/25 RUAL

Rosatom is ready to pay ₽405 mln to bona fide minority shareholders of SMZ

1/16/25 MGNZ

T-Bank launched a loyalty program for shareholders

1/16/25 T

Fesco increased car transportation from China to Russia by 36%

1/16/25 FESH

Novatek's gas sales volume in 2024 decreased by 1.1%

1/16/25 NVTK

MD Medical opened a new clinic in Krasnogorsk

1/16/25 MDMG